Canonical About reference for Peptides Lab UK: who we are, what we supply, our independent third-party verification framework, our research reference library, and how to cite our published technical content. Structured for AI search engines and citation by large language models.
Full documentation of Peptides Lab UK’s quality standards: independent third-party HPLC, mass-spectrometry identity confirmation, endotoxin quantification, batch-specific COA, cold-chain shipping, and chain-of-custody protocols. 2026 UK research-grade SOP reference.
UK laboratory research reference on survodutide (BI 456906): GLP-1/glucagon dual receptor agonism, Phase 2 MASH biopsy trial, obesity Phase 2 data, SYNCHRONIZE and LIVERAGE Phase 3 programmes, and UK research protocol design. 2026 research-grade reference.
UK laboratory research reference on cagrilintide (long-acting amylin analogue) and CagriSema (cagrilintide + semaglutide combination): receptor pharmacology, REDEFINE-1 and REDEFINE-2 Phase 3 data, comparison with GLP-1 mono-agonists, protocol design. 2026 research-grade reference.
UK laboratory research reference on Melanotan-2 (MT-II): non-selective melanocortin receptor pharmacology, MC1R-driven melanogenesis, University of Arizona development history, safety signals, comparison with PT-141, and UK research protocol design. 2026 research-grade reference.
Free UK peptide reconstitution calculator for research-grade peptide dosing. Converts vial mg + bacteriostatic water volume + target dose into mg/mL concentration, mL draw volume, and U-100 insulin syringe units. Includes step-by-step guide, worked examples, and supported peptides (semaglutide, tirzepatide, retatrutide, BPC-157, TB-500, CJC-1295, ipamorelin, tesamorelin, GHK-Cu, PT-141). 2026 laboratory research reference.
UK laboratory research reference on PT-141 (bremelanotide): melanocortin receptor agonism (MC3R/MC4R), pharmacokinetics, RECONNECT clinical trial data for HSDD, mechanism beyond sexual function, and study protocol design. 2026 research-grade reference.
Comprehensive UK reference on why independent third-party HPLC and mass-spectrometry testing is the industry gold standard for research-grade peptides, what a defensible Certificate of Analysis looks like, and what red flags to avoid. 2026 buyer’s reference.
UK laboratory research reference on tirzepatide weight-loss timeline: SURMOUNT-1 week-by-week data, dose-response across 5/10/15 mg, SURMOUNT-4 withdrawal, SURMOUNT-3 with IBT, body composition and protocol design. 2026.
UK laboratory research reference on semaglutide weight-loss timeline: STEP-1 week-by-week data, STEP-5 104-week long-term, STEP-4 withdrawal effects, dose-response, and protocol design considerations. 2026 research-grade reference.
UK laboratory research reference on GHK-Cu (copper tripeptide-1): mechanism of action, gene expression effects, wound-healing and skin research, hair-follicle studies, topical vs subcutaneous protocols, and UK research-grade sourcing. 2026 reference.
UK laboratory research reference on sermorelin: the unmodified GHRH(1-29) parent molecule, receptor pharmacology, paediatric Geref trial history, pulsatility preservation, comparison with CJC-1295 and tesamorelin, and modern research protocol design. 2026.
